Ogawa Naoto, Saito Maki, Mori Asami, Sakamoto Kenji, Kametaka Sokichi, Nakahara Tsutomu, Ishii Kunio
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.
Naunyn Schmiedebergs Arch Pharmacol. 2007 Jul;375(5):323-8. doi: 10.1007/s00210-007-0165-7. Epub 2007 May 25.
We examined the effect of nicorandil on retinal blood vessels in rats in vivo. Male Wistar rats (8 to 10 weeks old) were anaesthetised with thiobutabarbital (120 mg/kg, intraperitoneal). Fundus images were captured with a digital camera that was equipped with a special objective lens. Diameters of retinal blood vessels were measured with a personal computer. Nicorandil (1-300 microg kg(-1) min(-1), intravenous [i.v.]) increased diameters of retinal blood vessels and decreased systemic blood pressure in a dose-dependent manner. Both responses to nicorandil were attenuated by glibenclamide (20 mg/kg, i.v.), an adenosine triphosphate (ATP)-dependent K(+) (K(ATP)) channel blocker. On the other hand, indomethacin (5 mg/kg, i.v.), a cyclooxygenase inhibitor, attenuated the vasodilation of retinal blood vessels, but not depressor response, to nicorandil and sodium nitroprusside. Pinacidil (1-300 microg kg(-1) min(-1), i.v.), a K(ATP) channel opener, also dilated retinal blood vessels and decreased systemic blood pressure. The responses to pinacidil were prevented by glibenclamide, but not by indomethacin. The vasodilation of retinal arteriole, but not depressor response, to sodium nitroprusside (1-30 microg kg(-1) min(-1), i.v.), a nitric oxide donor, was attenuated by indomethacin. These results suggest that nicorandil dilates retinal blood vessels through opening of K(ATP) channels and production of prostaglandins that are probably generated by nitric oxide.
我们在体内研究了尼可地尔对大鼠视网膜血管的作用。雄性Wistar大鼠(8至10周龄)用硫喷妥钠(120 mg/kg,腹腔注射)麻醉。用配备特殊物镜的数码相机拍摄眼底图像。用个人计算机测量视网膜血管直径。尼可地尔(1 - 300 μg kg⁻¹ min⁻¹,静脉注射)以剂量依赖的方式增加视网膜血管直径并降低全身血压。对尼可地尔的这两种反应均被格列本脲(20 mg/kg,静脉注射)减弱,格列本脲是一种依赖三磷酸腺苷(ATP)的钾(KATP)通道阻滞剂。另一方面,吲哚美辛(5 mg/kg,静脉注射),一种环氧化酶抑制剂,减弱了尼可地尔对视网膜血管的舒张作用,但不影响对尼可地尔和硝普钠的降压反应。吡那地尔(1 - 300 μg kg⁻¹ min⁻¹,静脉注射),一种KATP通道开放剂,也能扩张视网膜血管并降低全身血压。对吡那地尔的反应被格列本脲阻断,但不被吲哚美辛阻断。吲哚美辛减弱了硝普钠(1 - 30 μg kg⁻¹ min⁻¹,静脉注射),一种一氧化氮供体,对视网膜小动脉的舒张作用,但不影响降压反应。这些结果表明,尼可地尔通过开放KATP通道和产生可能由一氧化氮生成的前列腺素而扩张视网膜血管。